Deutsche Bank
FURX

Deutsche Bank’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Deutsche Bank’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-22,214
Closed -$2.36M – 6413
2014
Q2 		$2.36M Buy
22,214
+2,952
+15% +$290K ﹤0.01% 2342
2014
Q1 		$1.68M Sell
19,262
-746
-4% -$57.6K ﹤0.01% 2517
2013
Q4 		$839K Buy
20,008
+6,510
+48% +$268K ﹤0.01% 2767
2013
Q3 		$592K Buy
13,498
+2,742
+25% +$113K ﹤0.01% 3358
2013
Q2 		$364K Buy
+10,756
New +$378K ﹤0.01% 3370

Deutsche Bank's FURX Position: Q3 2014 in Review

Deutsche Bank sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 22,214 shares — an estimated $2.36M sold.

Deutsche Bank first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $2.36M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Deutsche Bank reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Deutsche Bank sold 22,214 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $2.36M.
  • Deutsche Bank first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Deutsche Bank's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $2.36M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Deutsche Bank's 13F filing for Q3 2014, filed 14 Nov 2014.